Clinical Trials Logo

Ventilatory Depression clinical trials

View clinical trials related to Ventilatory Depression.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT01123486 Withdrawn - Pain Clinical Trials

Hydromorphone Pharmacokinetic-Pharmacodynamic Fingerprint

Start date: January 2015
Phase: N/A
Study type: Interventional

The primary objective of the proposed work is development of a high resolution pharmacokinetic-pharmacodynamic (PK-PD) model of hydromorphone for experimental pain stimuli, ventilatory depression, and surrogate biomarkers of opioid effect that will allow the fingerprinting of hydromorphone. This fingerprint will serve as the basis for the development of dosing strategies that efficiently maximize analgesia while minimizing ventilatory depression and sedation. For example, this high-resolution fingerprint will allow precise estimation of an initial hydromorphone target effect site concentration (Ce) from those of effectively administered synthetic opioids with previously determined high-resolution fingerprints (i.e., remifentanil or fentanyl), thereby minimizing underdosing of hydromorphone for analgesia and minimizing side effects.